Home Application of pyrosequencing to the identification of sequence variations in the cystic fibrosis transmembrane conductance regulator gene
Article
Licensed
Unlicensed Requires Authentication

Application of pyrosequencing to the identification of sequence variations in the cystic fibrosis transmembrane conductance regulator gene

  • Caterina Mari , Francesca Bruno , Silvia Galbiati , Anna Torri , Federica Lombardo , Manuela Seia , Maurizio Ferrari , Gabriella Restagno and Laura Cremonesi
Published/Copyright: September 1, 2009

Abstract

Background: A high number of mutations associated with cystic fibrosis have been identified in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, most of which are rare and, therefore, hamper extensive molecular diagnosis. In couples undergoing prenatal diagnosis where no mutation is found in one or both partners, additional analysis of intragenic polymorphisms may allow for the identification of fetal alleles associated with cystic fibrosis.

Methods: We developed novel, rapid and accurate assays for CFTR genotype determination using pyrosequencing technology; a simple, automated and reliable technique with low cost.

Results: Assays were optimized for the identification of the seven most frequent CFTR mutations (p.DeltaF508, p.N1303K, p.G542X, c.2183AA>G, c.1717-1G>A, p.W1282X, p.R1162X) in the Italian population and two common intragenic polymorphisms (rs213950 and rs1800136). Blind validation on 15 known control samples, typed for each sequence variation, allowed correct identification of all 135 genotypes.

Conclusions: We demonstrated that this procedure is highly specific for the identification of individual CFTR sequence variations associated with cystic fibrosis, allowing both population screening and prenatal diagnosis.

Clin Chem Lab Med 2009;47:1051–4.


Corresponding author: Dr. Laura Cremonesi, Genomic Unit for the Diagnosis of Human Pathologies, Center for Genomics, Bioinformatics, and Biostatistics, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, Italy Phone: +39 02 26434779, Fax: +39 02 26434351,

Received: 2009-2-23
Accepted: 2009-6-26
Published Online: 2009-09-01
Published in Print: 2009-09-01

©2009 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorials
  2. Estimating glomerular filtration rate
  3. Serum-free light chain analysis: works in progress
  4. Review
  5. Glomerular filtration rate measurement and prediction equations
  6. Genetics and Molecular Diagnostics
  7. Leptin gene (TTTC)n microsatellite polymorphism in pre-eclampsia and HELLP syndrome
  8. TaqIB polymorphism in cholesterol ester transfer protein (CETP) gene predicts future cardiovascular death in patients experiencing an acute coronary syndrome
  9. Peroxisome proliferator-activated receptor-γ (PPARγ) Pro12Ala polymorphism and risk for pediatric obesity
  10. Application of pyrosequencing to the identification of sequence variations in the cystic fibrosis transmembrane conductance regulator gene
  11. General Clinical Chemistry and Laboratory Medicine
  12. Relationship of serum bilirubin concentrations to kidney function and albuminuria in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001–2006
  13. Efficiency of test report delivery to the requesting physician in an outpatient setting: an observational study
  14. A case-control study on the relationship between HDL2b and non-alcoholic fatty liver disease in Chinese type 2 diabetic patients
  15. Preeclamptic placental stress and over expression of mitochondrial HSP70
  16. Reliability of two different bedside assays for C-reactive protein in newborn infants
  17. Clinical relevance of circulating midkine in ulcerative colitis
  18. First automated assay for thyrotropin receptor autoantibodies
  19. Serum concentrations of extracellular fatty acid synthase in patients with steatohepatitis
  20. Cancer Diagnostics
  21. Serum free light chains: diagnostic and prognostic value in multiple myeloma
  22. Quantitation of serum free light chains does not compensate for serum immunofixation only when screening for monoclonal gammopathies
  23. Serum HER-2 concentrations for monitoring women with breast cancer in a routine oncology setting
  24. Level of selenoprotein transcripts in peripheral leukocytes of patients with bladder cancer and healthy individuals
  25. Pre-treatment serum and plasma levels of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) in gastric cancer patients
  26. Infectious Disease
  27. Diagnosis of infection with human herpes viruses in routine laboratory practice
  28. Isolation and expression of UB05, a Plasmodium falciparum antigen recognised by antibodies from semi-immune adults in a high transmission endemic area of the Cameroonian rainforest
  29. Letters to the Editor
  30. Use of EDTA-plasma gel-separating tubes for measurement of indocyanine green
  31. Composition of cryoglobulin and cryoprecipitate
  32. Congress Abstracts
  33. Congress of Clinical Chemistry and Laboratory Medicine. 6th Annual Conference of the German Society for Clinical Chemistry and Laboratory Medicine (DGKL), Leipzig, Germany, October 7–10, 2009
  34. 8th Panhellenic Clinical Chemistry Congress, Patras, Greece, October 2–4, 2009
Downloaded on 11.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.262/html
Scroll to top button